Sandy Rowland
Analyst · Baird
Thanks Patrick. We have continued to see steady quarter sequential growth improvement across our businesses since the low point in April. And this quarter, we took another meaningful step forward. Fourth quarter revenue growth was down 2% organically versus the same period last year. That performance exceeded our expectations with upside in all of our end markets and geographically strong growth in China and Europe. I will touch on revenue performance in more detail covering each of the segments, but in short, utilities and industrial were both down 3%, commercial was flat and residential was up 15%. We also saw a quarter sequential improvement in orders. Organic orders were down 1% in the quarter as we delivered a second consecutive quarter of sequential orders improvement. This result most notably reflects the return to growth in M&CS orders, which delivered double-digit gains, including the large win in Houston, which Patrick mentioned. Applied Water contributed solid mid-single-digit growth and Water Infrastructure orders grew mid-single digits excluding the scope production of a project in India. We're still negotiating with the customer, but felt it was most prudent to reflect the scope production now. Otherwise orders growth would have been high single digits for Xylem overall. With orders accelerating and several large contract wins contributing to double-digit growth in backlog, we have good visibility of future revenue streams heading into 2021. I'm very pleased with the team's operational execution and cost discipline. Fourth quarter operating margin and EBITDA margin of 13.8% and 18.8% respectively are above our forecasted range. Compared to the prior year, lower volumes and unfavorable mix were partly offset by strong productivity and cost discipline. I'll review operating margin performance by segment in a moment. Our EPS in the quarter was $0.81 due to higher than forecasted revenue and earnings and from a lower tax rate due to favorable jurisdictional mix. Please turn to Slide 6 and I'll review our segment performance for the quarter. Water Infrastructure orders in the fourth quarter were down 16% organically versus last year. As I mentioned a moment ago that decline was driven by the descoped India project, otherwise orders would have been up mid-single digits reflecting healthy momentum in the segment as a whole, particularly in the wastewater utility businesses. Notably treatment was up 10% as wastewater utility CapEx budgets continue to show resilience globally. Water infrastructure revenue was flat organically in the quarter. Modest growth in wastewater utilities was offset by modest declines in our industrial businesses. Geographically, results were mixed, the U.S. was down high single digits, while Europe and emerging markets were up low-single digits and mid-single digits respectively. These results generally reflect the stage of COVID recovery in each region. Operating margin and EBITDA margin for the segment were down a modest 60 to 70 basis points respectively. Significant savings from productivity and cost reductions were offset by inflation, the recognition of reserves, and negative mix from declines in our U.S. dewatering rental business. Please turn to Page 6. In the Applied Water segment orders were up 4% organically in the quarter, driven by strong demand in Europe and emerging markets, partly offset by modest softness in the U.S. Revenue declined 1% in the quarter, mid-teens growth in residential was offset by softness in industrial, commercial revenue was flat. From a geographic perspective, the U.S. was down mid single-digits as COVID impacts drove declines in the industrial and commercial businesses, offset by that strong residential growth that I just mentioned. Europe delivered high single-digit growth primarily driven by good pace in commercial and modest growth in residential. Emerging markets were down low-single digits. Softness in industrial markets in the Middle East were partially offset by strength in the residential and industrial markets in China. Segment operating margin and EBITDA margin declined 90 and 170 basis points respectively. Volume declines in the industrial end market and overall inflation more than offset solid productivity gains, favorable mix and some price realization in the quarter. Now let's turn to Slide 7 and I'll cover our Measurement & Control Solutions business. In M&CS orders return to growth in the quarter, up 13% organically. This was largely driven by double-digit growth in both water and energy. Orders in our test business were up low single-digits. Revenue improved considerably on a sequential basis from the mid-teen declines we experienced in the second and third quarters. This quarter we finished the quarter, down 5%. While our core U.S. metrology business continued to experience COVID-19 related softness. The largest decline is related to the timing of project deployments. Large scale projects that were in process, pre-pandemic in both the U.S. and the Middle East have been completed. And new projects, which are part of our backlog have been temporarily delayed due to site access restrictions. We expect that large project deployments will resume towards the end of the second quarter and further accelerate in the back half of the year. These declines were partly offset by high single-digit growth in our analytics and advanced digital solutions businesses. Geographically, the U.S. was down mid-single digits for the reasons I just mentioned. Emerging markets was down double-digits due to the timing of prior year project deployments in the Middle East. And Europe grew double-digits from demand in the test business and from the start of the Anglian Water metrology project in the UK. Segment operating income and EBITDA margins in the quarter were down 330 and 350 basis points respectively. Lower volume inflation and favorable mix were partially offset by strong productivity and cost discipline. Now let's turn to Slide 8 for an overview of cash flows and the company's financial position. I was particularly pleased with our strong cash performance for the year. We grew free cash flow by 5% for the full year, exceeding our pre-pandemic free cash flow outlook and delivered free cash flow conversion of 181%. Our team has been focused on driving continuous improvement on working capital for a number of years. In the difficult operating environment of 2020, they took that work another step forward finishing at 17.6% of revenue. This is a 40 basis point improvement year-on-year, excluding foreign exchange impacts and reflects the team's progress in managing inventories and driving solid improvements in accounts receivable collections. We benefited from favorable timing related to the settlement of restructuring tax interest and payroll liabilities, some of which will reverse in 2021. Our balance sheet is well positioned and includes a $1.9 billion cash balance. Net debt to EBITDA leverage is 1.5 times. As a reminder, we'll take advantage of our cash position to repay one of our senior notes amounting to $600 million in the fourth quarter. And lastly, we announced an annual dividend increase of 8%. This is our 10th consecutive annual increase. Please turn to Page 9 and I'll turn the call back over to Patrick to look forward at 2021.